Sponsored By
alt text

Recent FTC ruling discourages supplement research, Washington lawyer saysRecent FTC ruling discourages supplement research, Washington lawyer says

A proposed FTC consent decree finds that a study for BrainStrong was not sufficient to make congitive claims. Venable partner Todd Harrison says the high standard discourages research.

Rick Polito

July 15, 2014

2 Min Read
Recent FTC ruling discourages supplement research, Washington lawyer says
<p>FTC saying BrainStrong study not robust enough for claims.</p>

Todd Harrison says the cracks in DSHEA gaped a bit wider last month with the FTC’s proposed consent decree limiting claims by iHealth and Martek Biosciences for the BrainStrong Adult cognitive function supplement. The decree is a “shot through the heart” of the supplement industry, says Harrison, partner in Venable, a Washington D.C. law firm, and he worries whether the industry can mount the sort of response needed.

About the Author(s)

Rick Polito

Editor-in-chief, Nutrition Business Journal

As Nutrition Business Journal's editor-in-chief, Rick Polito writes about the trends, deals and developments in the natural nutrition industry, looking for the little companies coming up and the big money coming in. An award-winning journalist, Polito knows that facts and figures never give the complete context and that the story of this industry has always been about people.

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like